Opportunity ID: 333778

General Information

Document Type: Grants Notice
Funding Opportunity Number: RFA-DA-22-012
Funding Opportunity Title: Assessing the Effects of Cannabinoids on HIV-Associated Persistent Inflammation (R01 Clinical Trial Optional)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Education
Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.279 — Drug Abuse and Addiction Research Programs
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: May 24, 2021
Last Updated Date: May 24, 2021
Original Closing Date for Applications: Aug 05, 2021
Current Closing Date for Applications: Aug 05, 2021
Archive Date: Sep 10, 2021
Estimated Total Program Funding:
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: For profit organizations other than small businesses
Public and State controlled institutions of higher education
Native American tribal organizations (other than Federally recognized tribal governments)
Public housing authorities/Indian housing authorities
City or township governments
Native American tribal governments (Federally recognized)
Small businesses
Special district governments
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Private institutions of higher education
Others (see text field entitled “Additional Information on Eligibility” for clarification)
State governments
County governments
Independent school districts
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Additional Information

Agency Name: National Institutes of Health
Description: The purpose of this Funding Opportunity Announcement [FOA] is to encourage basic science and preclinical research to determine the biological mechanisms underlying the effects of cannabinoids and the endocannabinoid system on HIV-associated persistent inflammation and its consequent effects on nervous system function. Projects submitted in response to this FOA must include expertise and resources in both areas of HIV/AIDS and addiction science.
Link to Additional Information: http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-22-012.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster
grantsinfo@nih.gov
Email:grantsinfo@nih.gov

Version History

Version Modification Description Updated Date

Related Documents

Packages

Agency Contact Information: NIH OER Webmaster
grantsinfo@nih.gov
Email: grantsinfo@nih.gov
Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
FORMS-F Use for due dates on or after May 25, 2020 PKG00267350 Jul 05, 2021 Aug 05, 2021 View

Package 1

Mandatory forms

333778 RR_SF424_2_0-2.0.pdf

333778 PHS398_CoverPageSupplement_5_0-5.0.pdf

333778 RR_OtherProjectInfo_1_4-1.4.pdf

333778 PerformanceSite_2_0-2.0.pdf

333778 RR_KeyPersonExpanded_2_0-2.0.pdf

333778 PHS398_ResearchPlan_4_0-4.0.pdf

333778 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf

Optional forms

333778 RR_Budget_1_4-1.4.pdf

333778 RR_SubawardBudget30_1_4-1.4.pdf

333778 PHS398_ModularBudget_1_2-1.2.pdf

333778 PHS_AssignmentRequestForm_3_0-3.0.pdf

2025-07-11T09:46:59-05:00

Share This Post, Choose Your Platform!

About the Author: